Contemporary Pharmacotherapy of Overactive Bladder

1. Front Matter

   Pages i-xv

   PDF

2. Pathophysiology of Overactive Bladder

   • Márcio Augusto Averbeck, Howard B. Goldman

   Pages 1-12

3. Diagnosis of Overactive Bladder

   • Eric S. Rovner, Jennifer Rolef

   Pages 13-25

4. The Placebo Effect in Overactive Bladder Syndrome

   • Svjetlana Lozo, Peter K. Sand

   Pages 27-45

5. Outcome Measures and Patient Expectations for Overactive Bladder

   • Gary E. Lemack, Rena D. Malik

   Pages 47-65

6. National and International Guidelines for Overactive Bladder

   • Lindsey Cox

   Pages 67-83

7. Antimuscarinic Pharmacotherapy for Overactive Bladder

   • Ariana L. Smith, Alan J. Wein

   Pages 85-113

8. β3-Agonists for Overactive Bladder

   • Sophia Delpe Goodridge, Roger R. Dmochowski

   Pages 115-131

9. Combination Pharmacotherapy for Overactive Bladder

   • Joon Jae Park, Christopher R. Chapple

   Pages 133-148

10. Behavioral Therapy in Combination with Pharmacotherapy

    • Cristiano Mendes Gomes, Marcelo Hisano

    Pages 149-161

11. Pharmacotherapy for Nocturia

    • Ari M. Bergman, Jeffrey P. Weiss

    Pages 163-176

12. Intravesical Chemodenervation and Toxins

    • Melissa T. Sanford, David A. Ginsberg

    Pages 177-204

13. Other Treatments for Overactive Bladder, Including Intravesical

    • Alison C. Levy, Lara S. MacLachlan

    Pages 205-218

14. Future Considerations in Overactive Bladder Pharmacotherapy

    • Karl-Erik Andersson

    Pages 219-229

15. Considerations in Pediatric Overactive Bladder

    • Alyssa Greiman, Andrew A. Stec

    Pages 231-244

16. Considerations in Male Overactive Bladder

    • Alex Gomelsky, Emily F. Kelly, Rebecca Budish

    Pages 245-265

17. Considerations in the Medically Complex and Frail Elderly

    • Adrian Wagg

    Pages 267-290

18. Individualizing Drug Therapy

    • Ricardo Palmerola, Victor Nitti

    Pages 291-314

19. Back Matter

    Pages 315-321

    PDF

This text provides a comprehensive, state-of-the art review of pharmacotherapy for the overactive bladder, and serve as a valuable resource forclinicians, surgeons, and researchers with an interest in OAB. The early chapters will describe the pathophysiology of OAB, algorithm, and provide the readers with a practical guide for evaluating the OAB patient. The next section describes the unique challenges involved in the study of OAB and helps the reader navigate the complexities of the literature on the topic. All chapters are written by experts in their fields and include the most up-to-date scientific and clinical information. The text includes a review of the clinical guidelines for OAB, and a detailed description of the individual therapies, including antimuscarinics, Beta-3 agonists, (insert comma) and chemodenervation. Extensive tabulation of contemporary literature makes this a matchless resource that provides a detailed account of the current evidence for the use of each of these therapies. The text concludes with chapters on unique populations with OAB, and future directions in the research field.

Contemporary Pharmacotherapy of Overactive Bladder unites a unique set of thought leaders in the field of voiding dysfunction to create a comprehensive resource that will be useful for a variety of clinicians who treat OAB, including urologists, urogynecologists, general gynecologists, family practitioners, and geriatricians.

• voiding dysfunction
• OAB
• Nocturia
• Intravesical chemodenervation
• Pediatric OAB
• Antimuscarinic pharmacotherapy

• Department of Urology, Medical University of South Carolina, Charleston, USA

  Lindsey Cox, Eric S. Rovner

Lindsey Cox, MDAssistant Professor of Urology
Department of Urology 
Medical University of South Carolina
96 Jonathan Lucas St. CSB 620
Charleston, SC 29425




Eric S. Rovner, MD
Professor of Urology
Department of Urology 
Medical University of South Carolina
96 Jonathan Lucas St. CSB 620
Charleston, SC 29425

Policies and ethics